Cell and Gene Therapy professional with focus in Viral Vector Manufacturing and Operations, Commercial and Business Development
It’s difficult to navigate the balance phase-appropriate needs with commercial readiness during cell and gene therapy development. Partnering with a trusted and experienced viral vector #CDMO can help unlock unique insights and provide guidance to achieve the right balance for your therapeutic. Here are 4 recommendations to keep in mind during preclinical and clinical development in our recent article